Mixed müllerian tumors of the uterus: a clinicopathologic study
- PMID: 2548134
Mixed müllerian tumors of the uterus: a clinicopathologic study
Abstract
Forty-seven cases of mixed müllerian tumors of the uterus were analyzed clinically and pathologically. All patients but one were postmenopausal. Vaginal bleeding was the most frequent presenting symptom, followed by abdominal mass and pelvic pain. Long-term survival was found only in those cases in which the tumor was localized to the uterus (surgical stage I), particularly if it arose from a benign endometrial polyp. No correlation could be established between survival and tumor size, depth of myometrial invasion, or histologic type of sarcoma. Tumors arising after previous irradiation had a poor prognosis. Treatment included surgery, radiation, and chemotherapy. The cumulative probability of 5-year survival was 35%.
Similar articles
-
Prognostic features of sarcomas and mixed tumors of the endometrium.Obstet Gynecol. 1984 Apr;63(4):550-6. Obstet Gynecol. 1984. PMID: 6322081
-
[Malignant mesodermal mixed tumor of the uterus--a study of 37 cases].Zhonghua Zhong Liu Za Zhi. 1991 Sep;13(5):378-80. Zhonghua Zhong Liu Za Zhi. 1991. PMID: 1664319 Chinese.
-
[Sarcoma of the endometrium. Epidemiology and prognostic factors. Apropos of a study of 22 cases].J Gynecol Obstet Biol Reprod (Paris). 1989;18(7):885-9. J Gynecol Obstet Biol Reprod (Paris). 1989. PMID: 2614028 French.
-
Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus.Int J Gynecol Pathol. 1998 Jul;17(3):211-22. Int J Gynecol Pathol. 1998. PMID: 9656116 Review.
-
Mixed mesodermal tumors of the ovary: a clinicopathologic study of 14 cases.Obstet Gynecol. 1988 Sep;72(3 Pt 1):409-12. Obstet Gynecol. 1988. PMID: 2841630 Review.
Cited by
-
Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08).J Gynecol Oncol. 2016 Nov;27(6):e58. doi: 10.3802/jgo.2016.27.e58. Epub 2016 Jul 11. J Gynecol Oncol. 2016. PMID: 27550404 Free PMC article.
-
Is the sarcomatous component (homologous vs heterologous) the prognostic "driving force" in early-stage uterine carcinosarcomas? A retrospective multicenter study.J Cancer Res Clin Oncol. 2023 Aug;149(9):6479-6488. doi: 10.1007/s00432-023-04594-5. Epub 2023 Feb 11. J Cancer Res Clin Oncol. 2023. PMID: 36773091 Free PMC article.
-
Different expression patterns of KIT, EGFR, and HER-2 (c-erbB-2) oncoproteins between epithelial and mesenchymal components in uterine carcinosarcoma.Cancer Sci. 2003 Nov;94(11):986-91. doi: 10.1111/j.1349-7006.2003.tb01389.x. Cancer Sci. 2003. PMID: 14611676 Free PMC article.
-
Clinico-Pathological Characteristics, Management, and Prognostic Factors of Patients with Uterine Carcinosarcoma: a Retrospective Analysis.Indian J Surg Oncol. 2023 Jun;14(2):466-472. doi: 10.1007/s13193-022-01563-1. Epub 2022 Aug 8. Indian J Surg Oncol. 2023. PMID: 37324314 Free PMC article.
-
Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers.Int J Gynecol Cancer. 2011 Jul;21(5):877-84. doi: 10.1097/IGC.0b013e31821a62dd. Int J Gynecol Cancer. 2011. PMID: 21666484 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical